You have read all your free articles, to continue reading subscribe to read the rest of this content.
Alligator Bioscience has announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application, allowing the company to initiate the OPTIMIZE-2 Phase 2 trial evaluating its lead asset mitazalimab in urothelial carcinoma. This open-label, mAlready a subscriber Login You have read all your…
BC Platforms has signed a contract with Nexus Personalized Health Technologies to create a joint translational research driven offering connecting genetic and clinical information to enable new innovative patient centric solutions in healthcare. Nexus is a provider of services to biomedical reseaAlready a subscriber Login You have read all your…
Swedish diabetes company Atrogi has recently completed a rights issue, and among the anchor investors is South Korea’s largest venture capital company Korea Investment Partners (KIP). “We see the investment by such a strong and experienced player as KIP as powerful confirmation of our groundbAlready a subscriber Login You have…
Novo Nordisk has announced that it plans to invest more than 100 million euros in production facilities at its site in Chartres, France. The new facilities will be built on Novo Nordisk's existing 31,000 m2 site in Chartres, which produces a range of the company's insulin products as well as FleAlready…
